{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-090847","form_type":"8-K","ticker":null,"cik":"0000831547","company_name":"SPECTRUM PHARMACEUTICALS INC","filed_at":"2023-04-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.385408+00:00","generated_at":"2026-06-17T06:42:38.290985+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Spectrum Pharmaceuticals lowers stockholder meeting quorum to 33 1/3%","bullets":["Board approved Fourth Amended and Restated Bylaws effective March 30, 2023.","Quorum reduced from a majority to 33 1/3% of outstanding voting shares.","Change applies to all stockholder meetings for transaction of business."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-090847","json":"https://secwatch.observer/filing/0001193125-23-090847.json","markdown":"https://secwatch.observer/filing/0001193125-23-090847.md","text":"https://secwatch.observer/filing/0001193125-23-090847.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/831547/000119312523090847/0001193125-23-090847-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/831547/000119312523090847/d471040d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T06:42:38.290985+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"34531d2a32bea66dafe1b03b131c448db1c31a0d","claim":"SPECTRUM PHARMACEUTICALS INC: Amended quorum requirement for stockholder meetings from majority to 33 1/3% of issued and outstanding shares (effective 2023-03-30).","evidence_excerpt":"The Restated Bylaws amended the quorum requirement for the transaction of business at all meetings of stockholders from the holders of a majority, to the holders of 33 1/3%, of the Company’s issued and outstanding shares of stock entitled to vote thereat, present in person or represented by proxy.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/831547/000119312523090847/0001193125-23-090847-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2023-03-30"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}